Arrowhead Pharmaceut...
NasdaqGS:ARWR
$ 59,82
$-3,78 (-5,94%)
59,82 $
$-3,78 (-5,94%)
End-of-day quote: 03/06/2026

Quick Analysis

$-0,01
Earnings Per Share
$6,11
Revenue Per Share
11,86%
Operating Margin %
$8,38 B
Market Cap
$0,58 B
Long-Term Debt
Earnings Per Share
$-0,01
Revenue Per Share
$6,11
Operating Margin %
11,86%
Market Cap
$8,38 B
Long-Term Debt
$0,58 B

Financials

Year Year 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2010
EPS Earnings Per Share $-0,01 $-5,00 $-1,92 $-1,67 $-1,36 $-0,84 $0,69 $-0,65 $-0,47 $-1,31 $-1,43 $-1,15 $-1,18 $-1,90 $0,90
Earnings Earnings $-1,36M $-622,15M $-206,27M $-177,04M $-142,16M $-86,32M $66,04M $-59,94M $-35,17M $-97,16M $-85,16M $-62,88M $-45,67M $-29,72M $6,45M
RPS Revenue Per Share $6,11 $0,03 $2,24 $2,29 $1,32 $0,86 $1,76 $0,18 $0,42 $0,00 $0,01 $0,00 $0,01 $0,01 $0,00
Revenue Revenue $829,45M $3,55M $240,74M $243,23M $138,29M $87,99M $168,80M $16,14M $31,41M $0,16M $0,38M $0,18M $0,29M $0,15M $0,00M
OCF Operating Cash Flow $179,55M $-462,85M $-153,89M $-136,13M $171,22M $-95,39M $173,03M $-47,22M $0,00M $-64,43M $0,00M $-35,42M $-19,03M $0,00M $0,00M
FCF Free Cash Flow $156,89M $-604,32M $-330,63M $-188,91M $147,66M $-107,34M $161,03M $-48,64M $0,00M $-68,29M $0,00M $-37,13M $-19,33M $0,00M $0,00M
OM Operating Margin 11,86% 0,00% -85,16% -73,39% -107,77% -105,87% 36,25% 0,00% -117,79% 0,00% 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 100,00% 0,00%
FCFS Free Cash Flow Per Share $1,17 $-5,05 $-3,10 $-1,79 $1,42 $-1,07 $1,72 $-0,58 $-0,43 $-1,12 $-1,18 $-0,79 $-0,81 $-1,42 $-1,20
LT Debt Long-Term Debt $582,28M $734,54M $268,33M N/A N/A N/A N/A $2,10M $2,33M $2,53M N/A N/A $0,05M $0,84M N/A
Sha. Stocks 135,81M 124,43M 107,43M 106,01M 104,53M 102,76M 95,71M 92,22M 74,83M 74,17M 59,55M 54,68M 38,7M 15,64M 7,17M
×